Idelalisib Completed Phase 1 Trials for Chronic Lymphocytic Leukaemia (CLL) / Non-Hodgkin's Lymphoma (NHL) Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs